Stay updated on Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial
Sign up to get notified when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.

Latest updates to the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe page now shows a new revision label (v3.5.0) and removes the previous label (v3.4.3).SummaryDifference0.0%

- Check16 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This is a minor metadata change and does not alter study content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedA minor site update added Revision: v3.4.2 and removed the previous Revision: v3.4.1 notice along with the government funding lapse banner. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedA site-wide notice about a lapse in government funding was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check58 days agoChange DetectedShow glossary option added; new metadata labels include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check73 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4 with no visible changes to study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.